✦ LIBER ✦

207. Development of non-peptide antagonist ligands acting for CRF1 receptors

✍ Scribed by D.E. Grigoriadis; C. Chen; M.T. Lorang; K. Wilcoxen; X.-J. Liu; N. Ling

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of non-peptide corticotropin

✍ Dimitri E. Grigoriadis; Chen Chen; Marge Lorang; Keith Wilcoxen; Xin-Jun Liu; Ni 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 95 KB

The CRF1 receptor mediates the excitator

✍ Tallie Z Baram; Derek T Chalmers; Chen Chen; Yani Koutsoukos; Errol B De Souza 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Single amino acid residue determinants o

✍ Sam R.J. Hoare; Brock T. Brown; Mark A. Santos; Siobhan Malany; Stephen F. Betz; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 676 KB

Therapeutic utility of non-peptidic CRF1

✍ John H. Kehne; Christopher K. Cain 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 664 KB

‘Targeted’ molecular diversity: design a

✍ David Horwell; Martyn Pritchard; Jennifer Raphy; Giles Ratcliffe 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 313 KB

Pharmacological characterization of abbo

✍ A.A. Hancock; S.A. Buckner; J.Y. Lee; M. Brune; P.A. Morse; K. Oheim; R.B. Warne 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 483 KB